Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 18
Item hits:
Issue DateTitleAuthor(s)
12-Mar-2021Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population.Pallett, SJC; Denny, S; Patel, A; Charani, E; Mughal, N, et al
1-Jul-2021Circulating microRNAs in small-bowel neuroendocrine tumors: a potential tool for diagnosis and assessment of effectiveness of surgical resectionMalczewska, A; Frampton, AE; Mato Prado, M; Ameri, S; Dabrowska, AF, et al
14-Jun-2021EGFR-mutated squamous cell lung cancer and its association with outcomesJin, R; Peng, L; Shou, J; Wang, J; Jin, Y, et al
1-Jan-2021JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityStebbing, J; Nievas, GS; Falcone, M; Youhanna, S; Richardson, P, et al
4-Feb-2021What is the intermediate host species of SARS-CoV-2?Friend, T; Stebbing, J;
17-Mar-2021LMTK3 inhibition affects microtubule stabilityCilibrasi, C; Ditsiou, A; Papakyriakou, A; Mavridis, G; Eravci, M, et al
20-Jun-2021Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trialStebbing, J; Baranau, Y; Baryash, V; Manikhas, A; Moiseyenko, V, et al
7-Jun-2021Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patientsNteliopoulos, G; Page, K; Hills, A; Howarth, K; Emmett, W, et al
23-Jun-2021First-line treatment options for PD-L1-negative non-small cell lung cancer: a Bayesian network meta-analysisPeng, L; Liang, W-H; Mu, D-G; Xu, S; Hong, S-D, et al
29-Jul-2021JAK inhibitors — More than just glucocorticoidsStebbing, J; Lauschke, VM;